<DOC>
	<DOCNO>NCT01713348</DOCNO>
	<brief_summary>To understand Multiple Daily Injections ( MDI ) manage subject improve glycaemic control ; 1. regularly check understand Continuous Glucose data &amp; trend arrows time standard pre-meal bolus calculation test time 2. review glucose profile ( inc. hypoglycaemic risk ) Health Care Professional ( HCP ) adjusting behaviour &amp; therapy interpretation Continuous Glucose profile .</brief_summary>
	<brief_title>Sensor Software Use Improved Glucose Control MDI Managed Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Age 18 year Type 1 diabetes MDI bolus injection &gt; 6 month prior study enrolment Type 2 diabetes treat 2 insulin injection daily . In investigator 's opinion , think technically capable use FreeStyle Navigator GM System device . HbA1c 7.5 12.0 % ( 58 108 mmol/mol ) previous test obtain within 6 month prior point enrolment Concomitant disease condition may compromise patient safety , include unstable coronary heart disease , cystic fibrosis , serious psychiatric disorder , uncontrolled chronic medical condition Female subject pregnant planning become pregnant within plan study duration . Subjects become pregnant study discontinue study . Currently use / previously use Continuous Glucose Monitoring System within last 6 month . Currently use Continuous Subcutaneous Insulin Infusion ( CSII ) Currently use basal/long act insulin . Participating another study glucose monitoring device / drug could affect glucose measurement / management Known allergy medical grade adhesive In investigator opinion unsuitable participate due cause/reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>CGM</keyword>
	<keyword>MDI</keyword>
</DOC>